NEUMORA THERAPEUTICS INC (NMRA:NASDAQ)
$1.79 0.01 (0.5618%)
Analysed NEUMORA THERAPEUTICS INC (NMRA:NASDAQ) News Sources
Neumora Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Monday, March 30, 2026
16-03-2026
yahoo.com
Neumora Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
30-03-2026
yahoo.com
Neumora Therapeutics Q4 Earnings Call Highlights
30-03-2026
marketbeat.com
Neumora Therapeutics Inc (NMRA) Q4 2025 Earnings Call Highlights: Strong Financial Position ...
31-03-2026
yahoo.com
Neumora Therapeutics, Inc. Common Stock Q4 2025 Earnings Call Summary
31-03-2026
moby.co
Neumora Therapeutics to Participate in 25th Annual Needham Virtual Healthcare Conference
06-04-2026
yahoo.com
Neumora Therapeutics (NMRA) Is Among the Best Penny Stocks Set to Explode
12-04-2026
yahoo.com
Neumora Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
07-05-2026
yahoo.com
Neumora Therapeutics to Participate in 2026 RBC Capital Markets Global Healthcare Conference
12-05-2026
yahoo.com
SoftBank Just Dumped Circle Stock. Don’t Panic and Keep Adding CRCL Here.
19-05-2026
barchart.com
What is the current price of NEUMORA THERAPEUTICS INC (NMRA:NASDAQ)?
The current price of NEUMORA THERAPEUTICS INC (NMRA:NASDAQ) is $1.79.
NEUMORA THERAPEUTICS INC (NMRA:NASDAQ) absolute price change since previous trading day?
The absolute price change of NEUMORA THERAPEUTICS INC (NMRA:NASDAQ) since the previous trading day is $0.01.
NEUMORA THERAPEUTICS INC (NMRA:NASDAQ) percentage price change since previous trading day?
The percentage price change of NEUMORA THERAPEUTICS INC (NMRA:NASDAQ) since the previous trading day is 0.5618%.
What is the most recent average sentiment score for NEUMORA THERAPEUTICS INC (NMRA:NASDAQ)?
The most recent average sentiment score for NEUMORA THERAPEUTICS INC (NMRA:NASDAQ) is 78 out of 100.
What is the most recent average sentiment for NEUMORA THERAPEUTICS INC (NMRA:NASDAQ)?
The most recent sentiment for NEUMORA THERAPEUTICS INC (NMRA:NASDAQ) is .
SEC-8K** Filing Available For NEUMORA THERAPEUTICS INC (NMRA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.